We are live on ! Find out more
VCYT icon

Veracyte

193 hedge funds and large institutions have $1.52B invested in Veracyte in 2022 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 90 increasing their positions, 51 reducing their positions, and 34 closing their positions.

New
Increased
Maintained
Reduced
Closed

267% more call options, than puts

Call options by funds: $4.19M | Put options by funds: $1.14M

76% more repeat investments, than reductions

Existing positions increased: 90 | Existing positions reduced: 51

0.32% more ownership

Funds ownership: 108.07%108.39% (+0.32%)

0% more funds holding in top 10

Funds holding in top 10: 33 (0)

6% less funds holding

Funds holding: 205193 (-12)

26% less first-time investments, than exits

New positions opened: 25 | Existing positions closed: 34

28% less capital invested

Capital invested by funds: $2.11B → $1.52B (-$593M)

Holders
193
Holders Change
-12
Holders Change %
-5.85%
% of All Funds
3.24%
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
25
Increased
90
Reduced
51
Closed
34
Calls
$4.19M
Puts
$1.14M
Net Calls
+$3.05M
Net Calls Change
+$4.02M

VCYT Hedge Fund Activity: Q2 2022 in Review

193 of the 5,959 institutional investors tracked by Wall St. Rank reported a position in Veracyte (VCYT) for Q2 2022, worth a combined $1.52B — down 28% from $2.11B a quarter earlier.

Sellers outnumbered buyers: 34 funds closed out of VCYT and 25 opened new positions — a net loss of 9 holders — while 51 trimmed existing stakes and 90 added.

The largest buyer was State Street, adding an estimated $24.2M. The largest seller was William Blair Investment Management, cutting an estimated $58.9M.

  • 193 institutional investors held Veracyte (VCYT) as of Q2 2022, down from 205 in Q1 2022.
  • Funds reported $1.52B of Veracyte stock for Q2 2022, down 28% quarter-over-quarter.
  • 25 funds opened new Veracyte positions in Q2 2022 and 34 closed out, a net change of -9 holders.
  • The largest Veracyte buyer in Q2 2022 was State Street, an estimated $24.2M added.
  • The largest Veracyte seller in Q2 2022 was William Blair Investment Management, an estimated $58.9M sold.

Based on aggregated 13F filings for Q2 2022.